Clinical Trial Update: Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of mineralocorticoid receptor antagonist (MRA) on cardiovascular disease in patients with hypertension and hyperald…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperaldosteronism
• Hypertension

Snippet

Sponsor: Nanfang Li | Conditions: Hypertension, Hyperaldosteronaemia | Phase 4 | Status: ENROLLING_BY_INVITATION